Medinet Co Ltd
TSE:2370
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
37
55
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Medinet Co Ltd
Medinet Co Ltd
Cost of Revenue
Medinet Co Ltd
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Medinet Co Ltd
TSE:2370
|
Cost of Revenue
-¥624.2m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
1%
|
CAGR 10-Years
5%
|
|
|
CMIC Holdings Co Ltd
TSE:2309
|
Cost of Revenue
-¥72.3B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-6%
|
|
|
C
|
Chiome Bioscience Inc
TSE:4583
|
Cost of Revenue
-¥269.9m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-6%
|
|
|
Precision System Science Co Ltd
TSE:7707
|
Cost of Revenue
-¥3B
|
CAGR 3-Years
21%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-1%
|
|
|
CellSource Co Ltd
TSE:4880
|
Cost of Revenue
-¥1.3B
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
N/A
|
|
|
WDB coco Co Ltd
TSE:7079
|
Cost of Revenue
-¥2.7B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
Medinet Co Ltd
Glance View
MEDINET Co., Ltd. engages in cell processing business. The company is headquartered in Ota-Ku, Tokyo-To and currently employs 83 full-time employees. The company went IPO on 2003-10-08. The company operates through two business segments. The Cell Processing Industry segment mainly engages in comprehensive support services for immune cell therapy, related services including clinical use from companies, universities, research institutes, outsourcing of cell processing for clinical trials and operation of cell culture processing facilities. The Cellular Medical Products segment is mainly engaged in research and development for obtaining approval for manufacture and marketing of cellular medical products. The company also provides comprehensive support services for immune cell therapy.
See Also
What is Medinet Co Ltd's Cost of Revenue?
Cost of Revenue
-624.2m
JPY
Based on the financial report for Jun 30, 2024, Medinet Co Ltd's Cost of Revenue amounts to -624.2m JPY.
What is Medinet Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
5%
Over the last year, the Cost of Revenue growth was -14%. The average annual Cost of Revenue growth rates for Medinet Co Ltd have been -9% over the past three years , 1% over the past five years , and 5% over the past ten years .
You don't have any saved screeners yet
